Study of ZG005 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called ZG005 in people with advanced solid tumors that have not spread to the brain. It aims to see if the drug is safe and can help shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You understand the study and agree to join by signing a consent form.
- You are between 18 and 70 years old.
- You are well enough to be up and about at least half the day (ECOG 0-2).
- Your doctor expects you to live at least 3 more months.
- You have a confirmed advanced solid tumor (by biopsy or other tests).
- You have not had any other cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called ZL-6201 for people with sarcoma or certain solid tumors that have spread or cannot be removed. It aims to see if the drug is safe and helps shrink tumors.
This trial tests a new drug called ZG006 for people with advanced small cell lung cancer or a type of neuroendocrine cancer. It aims to find the best dose and see if it helps shrink tumors.
This trial tests a new drug, ZG006, for men with advanced neuroendocrine prostate cancer that has worsened after platinum-based chemotherapy or caused serious side effects. The goal is to see if ZG006 can help shrink or slow the cancer.
This Phase 1 trial tests a new experimental medicine (FZ-AD004) in adults with advanced solid tumors. It aims to see how the drug behaves in the body and whether it’s safe enough to continue in patients with measurable cancer.
This trial tests a new combination of two drugs, ZG005 and Gecacitinib, for people with advanced non-small cell lung cancer that cannot be treated with surgery or radiation. The goal is to see if the combination can shrink or slow the cancer.
This trial is testing a new combination of two drugs (ZGGS18 and ZG005) for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination is safe and effective.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.